Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lina Ding

Showing results (101-110 of 117) with videos related to

Pageof 12
Sort By:
Journal of Biomolecular Structure & Dynamics|October 28, 2018
Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screeningXu-Dong Sun, Yi-Chao Zheng, Chao-Ya Ma, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 16, 2025
Hu-gu-xiao-ji formula reprograms macrophage polarization and suppresses tumor growth to improve non-small cell lung cancer with bone metastasis via multiple signaling pathwaysJiao Wang, Gulizeba Muhetaer, Qiwei Lei, et al.
Journal of Medicinal Chemistry|September 30, 2020
Correction to Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M InteractionWenjuan Zhou, Liying Ma, Lina Ding, et al.
Journal of Medicinal Chemistry|June 4, 2019
Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M InteractionWenjuan Zhou, Liying Ma, Lina Ding, et al.
Acta Pharmaceutica Sinica. B|August 7, 2019
Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A)Zhonghua Li, Lina Ding, Zhongrui Li, et al.
G3 (Bethesda, Md.)|May 31, 2014
Validation of six genetic determinants of susceptibility to estrogen-induced mammary cancer in the rat and assessment of their relevance to breast cancer risk in humansJohn A Colletti, Kristin M Leland-Wavrin, Scott G Kurz, et al.
Chemical Reviews|April 9, 2015
The ONIOM Method and Its ApplicationsLung Wa Chung, W M C Sameera, Romain Ramozzi, et al.
Plos Genetics|March 21, 2019
Deletion of Cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environmentLina Ding, Lauren B Shunkwiler, Nicholas W Harper, et al.
Journal of Medicinal Chemistry|February 27, 2019
Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5- a]pyrimidine-Based Inhibitors Targeting the DCN1-UBC12 Protein-Protein InteractionShuai Wang, Lijie Zhao, Xiao-Jing Shi, et al.
Cell Death & Disease|June 6, 2019
Potent and specific MTH1 inhibitors targeting gastric cancerWenjuan Zhou, Liying Ma, Jing Yang, et al.
Pageof 12

Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Journal of Biomolecular Structure & Dynamics|October 28, 2018
Identifying the novel inhibitors of lysine-specific demethylase 1 (LSD1) combining pharmacophore-based and structure-based virtual screeningXu-Dong Sun, Yi-Chao Zheng, Chao-Ya Ma, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|October 16, 2025
Hu-gu-xiao-ji formula reprograms macrophage polarization and suppresses tumor growth to improve non-small cell lung cancer with bone metastasis via multiple signaling pathwaysJiao Wang, Gulizeba Muhetaer, Qiwei Lei, et al.
Journal of Medicinal Chemistry|September 30, 2020
Correction to Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M InteractionWenjuan Zhou, Liying Ma, Lina Ding, et al.
Journal of Medicinal Chemistry|June 4, 2019
Potent 5-Cyano-6-phenyl-pyrimidin-Based Derivatives Targeting DCN1-UBE2M InteractionWenjuan Zhou, Liying Ma, Lina Ding, et al.
Acta Pharmaceutica Sinica. B|August 7, 2019
Development of the triazole-fused pyrimidine derivatives as highly potent and reversible inhibitors of histone lysine specific demethylase 1 (LSD1/KDM1A)Zhonghua Li, Lina Ding, Zhongrui Li, et al.
G3 (Bethesda, Md.)|May 31, 2014
Validation of six genetic determinants of susceptibility to estrogen-induced mammary cancer in the rat and assessment of their relevance to breast cancer risk in humansJohn A Colletti, Kristin M Leland-Wavrin, Scott G Kurz, et al.
Chemical Reviews|April 9, 2015
The ONIOM Method and Its ApplicationsLung Wa Chung, W M C Sameera, Romain Ramozzi, et al.
Plos Genetics|March 21, 2019
Deletion of Cdkn1b in ACI rats leads to increased proliferation and pregnancy-associated changes in the mammary gland due to perturbed systemic endocrine environmentLina Ding, Lauren B Shunkwiler, Nicholas W Harper, et al.
Journal of Medicinal Chemistry|February 27, 2019
Development of Highly Potent, Selective, and Cellular Active Triazolo[1,5- a]pyrimidine-Based Inhibitors Targeting the DCN1-UBC12 Protein-Protein InteractionShuai Wang, Lijie Zhao, Xiao-Jing Shi, et al.
Cell Death & Disease|June 6, 2019
Potent and specific MTH1 inhibitors targeting gastric cancerWenjuan Zhou, Liying Ma, Jing Yang, et al.
Pageof 12